ArriVent BioPharma • AVBP
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$706M
Market Cap • 25/07/20242021
(há 3 anos)
2024
IPONASDAQ
Listagem
Philadelphia
Sede • PennsylvaniaValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
AVBPSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.